本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mereo Biopharma Group Plc

2.53
+0.04001.61%
成交量:205.11万
成交额:507.43万
市值:3.92亿
市盈率:-8.05
高:2.55
开:2.48
低:2.37
收:2.49
数据加载中...
2023/10/31

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/03/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/10/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/19

SEC问询函

CORRESP [Cover] - Correspondence